Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Adamis Family Values

|Includes:Adamis Pharmaceuticals Corp. (ADMP)

We mistakenly said that Advair comes off patent in 2016 in our email and last blog post, in fact Advair came off patent in 2010 - it is the Advair-delivering Diskus inhaler which comes off patent in early 2016, and which Adamis Dry Powder Inhaler is poised to compete:

The Food and Drug Administration yesterday revised guidelines for competitors to get copies on the market, saying long, expensive human tests aren't required to show drugs work the same as Advair. Advair, an inhaled medicine for asthma and chronic obstructive pulmonary disorder, is the world's third-best selling drug with revenue of 5.05 billion pounds ($7.95 billion) last year and accounts for about 20 percent of Glaxo's annual sales.

Disclosure: I am long ADMP.

Stocks: ADMP